|
|
|
|
|
|
|
Request your FREE Special Report today and you'll |
Biopharmaceutical company Targacept, Inc. (Nasdaq:TRGT) announced this morning it made a drug development deal potentially worth more than $1.5 billion with GlaxoSmithKline Plc (NYSE:GSK).
Targacept will host a conference call to discuss its latest deal today at 10 a.m. ET.
Shares of Targacept jumped 32.11%, or $2.89, to $11.89 in pre-market trading.
Join Daily Profit today and get our unique perspective and investment ideas in your inbox every day.
Please tell us where we can send your free subscription. Plus, as a free gift, I'll rush you a copy of my Top 10 Forever Stocks - a special bonus report.
Wyatt Investment Research
c/o Business Financial Publishing
65 Railroad Street
PO Box 790
Richmond, VT 05477
